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Inhibitory neuronrsal horn synthesize a variety of neurotransmitters, including GABA, glycine and
a set of peptides. Here we show that three transcription factors, Ptf1a, Pax2, and Lbx1, which have been
reported to promote a GABAergic cell fate, also specify glycinergic and peptidergic transmitter phenotypes.
First, Ptf1a appears to be a master regulator, as indicated by a requirement of Ptf1a for the expression of
glycinergic marker GlyT2 and a set of peptides, including neuropeptide Y (NPY), nociceptin/orphanin FQ (N/
OFQ), somatostatin (SOM), enkephalin (ENK), dynorphin (DYN) and galanin (GAL). Second, Pax2 is a
downstream target of Ptf1a and controls subsets of transmitter phenotypes, including the expression of
GlyT2, NPY, N/OFQ, DYN, and GAL, but is dispensable for SOM or ENK expression. Third, for Lbx1, due to
neuronal cell loss at late stages, our analyses focused on early embryonic stages, and we found that Lbx1 is
required for the expression of GlyT2, NPY, N/OFQ and is partially responsible for SOM expression. Our studies
therefore suggest a coordinated and hierarchical speciﬁcation of a variety of neurotransmitters in dorsal
spinal inhibitory neurons.
© 2008 Elsevier Inc. All rights reserved.IntroductionThe dorsal spinal cord integrates and transmits diverse somato-
sensory information from the periphery to the higher brain centers.
The neurons in the dorsal spinal cord can be generally grouped as
either excitatory neurons that use glutamate as their neurotransmitter
or inhibitory interneurons that useGABAor glycine as fast transmitters
(Allain et al., 2006; Bennett and Balcar, 1999; Todd et al., 2003; Todd
and Maxwell, 2000; Zeilhofer, 2005). Additionally, inhibitory neurons
synthesize a variety of peptide transmitters, such as enkephalin (ENK),
somatostatin (SOM), neuropeptide Y(NPY) and galanin (GAL) (Furst,
1999; Proudlock et al., 1993; Rowan et al., 1993; Simmons et al., 1995;
Todd et al., 1992). Functionally, inhibitory neurons are involved in
modulating the transmission of the somatic sensory information
carried by excitatory glutamatergic neurons (Dickenson, 2002;
Melzack andWall,1965; Torsney andMacDermott, 2006). In particular,
a reduction of inhibitory neuron activity in the dorsal horn has been
implicated in the development of chronic pain (Harvey et al., 2004;
Knabl et al., 2008; Torsney and MacDermott, 2006).
In the past several years, mechanisms that govern dorsal horn
neuron development are beginning to be understood (Caspary and
Anderson, 2003; Fitzgerald, 2005; Goulding et al., 2002; Helms andl rights reserved.Johnson, 2003). Six types of dorsal interneurons (DI1–DI6) are
generated during the ﬁrst wave of neurogenesis (E10.5–E11.5),
followed by the formation of two principal types of dorsal horn
neurons, DILA and DILB, during the late wave of neurogenesis (E11.5–
E13.5) (Gross et al., 2002; Muller et al., 2002). Homeodomain
transcription factor Lbx1 is expressed in early born DI4–6 neurons
and late born DILA and DILB neurons and Lbx1+ neurons can be
grouped into Pax2+ (DI4, DI6 and DILA) and Tlx3+ (DI5 and DILB)
(Cheng et al., 2004; Gross et al., 2002; Muller et al., 2002).
Interestingly, expression of Pax2 and Tlx3 is associated with
embryonic GABAergic and glutamatergic neurons, respectively
(Cheng et al., 2004). Tlx3 is necessary for the speciﬁcation of
glutamatergic cell fate (Cheng et al., 2004). Pax2 is a downstream
target of Lbx1 and Ptf1a, and all three transcription factors are
required to specify the GABAergic neuron cell fate (Cheng et al., 2004;
Glasgow et al., 2005; Gross et al., 2002; Muller et al., 2002).
Mechanistically, Tlx3 acts to antagonize Lbx1 protein activity, and
Ptf1a acts to suppress Tlx3 expression (Cheng et al., 2005; Glasgow et
al., 2005; Hori et al., 2008; Mizuguchi et al., 2006).
Despite the above progress, transcriptional regulation of the
glycinergic and peptidergic transmitter phenotypes in dorsal horn
inhibitory neurons is still poorly understood. In this study, by
analyzing Ptf1a, Pax2 and Lbx1 null embryos, we demonstrate that
these three transcription factors have partially overlapping roles in
coordinating these transmitter phenotypes.
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Mouse strains
The generation of Tlx1, Tlx3, Lbx1 and Pax2mutant mice have been
described previously (Gross et al., 2000; Roberts et al., 1994;
Shirasawa et al., 2000; Torres et al., 1995). Ptf1acre mutant mice,
which have Cre-recombinase in place of the Ptf1a protein-coding
region, were obtained from the Mutant Mouse Regional Resource
Centers (MMRRC) (Kawaguchi et al., 2002). The morning that vaginal
plugs were observed was designated as E0.5. Genotyping for Tlx1, Tlx3
and Lbx1 mutant mice was done as described previously (Gross et al.,
2000; Qian et al., 2002). Wild-type Pax2 allele was ampliﬁed with the
following primers that produce a 0.48 kb product: 5′-AGCA-
GACCCCTTCTCCGCGAT-3′ and 5′-GTTTGAGGAAGGTAAAGATGAGG-3′.
Mutant Pax2 allele was ampliﬁed with primers derived from neo gene
that produce a 0.53 kb product: 5′-TCGGCTATGACTGGGCACAACA-3′
and 5′-GATATTCGGCAAGCAGGCATCG-3′. Ptf1a mice genotyping was
done using PCR with primers: 5′-GACGAGCAAGCAGAAGTAGAGT-3′
and 5′-GCAGCGTGTCTACTTTGGAG-3′ for wild-type Ptf1a locus, and
with 5′-GCCTGCATTACCGGTCGATGC-3′ and 5′-CAGGGTGTTATAAG-
CAATCCCC-3′ for Cre in the mutant allele.
In situ hybridization and immunostaining
In situ hybridization experiments were performed as described
previously (Birren et al., 1993). The following mouse in situ probes
were ampliﬁed with gene-speciﬁc sets of PCR primers and cDNA
templates prepared from E12.5 or P0 mouse brain/spinal cord: Pnoc
(NM_010932, 0.75 kb), Pdyn (NM_018863, 0.79 kb), Npy
(NM_023456, 0.5 kb), GlyT2 (NM_148931, 1.2 kb), Penk1
(NM_001002927, 0.86 kb), Sst (NM_009215, 0.53 kb), Gal
(NM_010253, 0.36 kb). Chick GlyT2 (XM_420906, 0.80 kb) was
ampliﬁed with cDNA prepared from E8 chick spinal cord. Other in
situ probes were described previously (Cheng et al., 2004; Cheng et al.,
2005).
When in situ hybridization was combined with ﬂuorescent
immunostaining, in situ hybridization was ﬁrst performed with a
pre-treatment of proteinase K (2 µg/ml) for 5 min. After post-
hybridization washing, Pax2 protein was detected by incubation with
anti-Pax2 antibody (Zymed Laboratories Inc.) and then Alexa-488
conjugated secondary antibody (1:200, Molecular Probes) in PBT
solution. Alkaline phosphatase-conjugated anti-digoxigenin antibody
was then incubated, followed by developing in situ hybridization
signals with NBT/BCIP substrates. For generating the confocal images,
the bright ﬁeld images of in situ hybridization signals were converted
into pseudo-red ﬂuorescent color, and then merged with green
ﬂuorescent images.
In ovo electroporation
The cDNA fragments, which contain the full-length coding regions
of mouse Lbx1 (GenBank accession number NM_010691), Pax2
(GenBank accession number NM_011037), Ptf1a (GenBank accession
number NM_018809) and Lhx1 (GenBank accession number
NM_008498), were cloned into the RCASBP chick viral expression
vector (Morgan and Fekete, 1996). These constructs are referred to as
RCAS-Lbx1, RCAS-Pax2, RCAS-Ptf1a and RCAS-Lhx1 respectively. The
puriﬁed plasmid DNA was re-suspended at a concentration of 5 µg/µl
and injected into neural tubes of stage 13–14 chick embryos. The
control vector RCASBP plus a GFP expression vector, pCAX-IRES-GFP
(called pCAX-GFP) (Gross et al., 2002), were co-injected into the neural
tube. Following electroporation, the embryos were allowed to grow at
38 °C for a further 48 h. Embryos were then ﬁxed, and frozen sections
were then used for in situ hybridization. A minimum of 15 sections
from at least ﬁve independently electroporated embryos that scoredpositive for the phenotype relative to the control electroporationwere
evaluated.
TUNEL staining on cryostat sections
Apoptotic cells in the developing spinal cord were analyzed by the
TUNEL assay using the ApopTag-plus Fluorescein In Situ Apoptosis
Detection Kit (Chemicon International). Cell staining was performed
according to the manufacturer's protocols.
Cell counting
To count the numbers of Sst+, Penk1+, Pdyn+, Gal+, Npy+ and Pnoc+
cells, transverse sections from 3 pairs of wild-type and mutant
embryos (14-µm thickness) were hybridized with the peptide genes.
Positive cells in the dorsal spinal cord were counted and the values
were presented as mean±s.d.. The differences in values were
considered to be signiﬁcant at Pb0.05 by Student's t-test.
Results
Ptf1a, Lbx1 and Pax2 are required to specify the glycinergic neuron cell
fates
Pax2 is expressed in newly born GABAergic neurons in the dorsal
spinal cord (Cheng et al., 2004). It has also been reported that all
glycine-immunoreactive cell bodies are also GABA-immunoreactive in
lamina I through III of the rat dorsal horn, and GABA and glycine are
frequently co-localized in axon terminals throughout the spinal gray
matter (Todd, 1996; Todd and Sullivan, 1990). We therefore wanted to
examine if Pax2 is expressed in developing glycinergic neurons.
Glycine transporter 2 (GlyT2), which is responsible for glycine re-
uptake to terminate the synaptic action of glycine, has been shown to
be a reliable marker for glycinergic neurons (Poyatos et al., 1997; Spike
et al., 1997). Because the GlyT2 protein is present predominantly in
axons and axonal boutons, we decided to detect GlyT2 mRNA
expression for the presence of glycinergic neurons (Spike et al.,
1997). Double staining of GlyT2 mRNA in the cytoplasm and Pax2
protein in the nuclei showed that GlyT2 overlapped extensively with
Pax2 in the E12.5 dorsal spinal cord, but some dorsal horn neurons
expressed only GlyT2 or Pax2 (Figs. 1A and B). Partial overlapping
expression of GlyT2 and Pax2 was also observed at P0 (Figs. 1C and D).
Since GlyT2 expression is largely eliminated in Pax2 mutant dorsal
horns at E12.5 (see below), we concluded that Pax2 is expressed either
persistently or transiently in most dorsal horn glycinergic neurons.
We and others have demonstrated that speciﬁcation of the
GABAergic transmitter phenotype is dependent on Lbx1, Pax2, and
Ptf1a (Cheng et al., 2004, 2005; Glasgow et al., 2005; Gross et al.,
2002; Muller et al., 2002). Here we wanted to determine if Ptf1a, Pax2
and Lbx1 were also involved in specifying the glycinergic transmitter
phenotype and so we analyzed mice deﬁcient in these genes.
In Ptf1a−/− null embryos at stage E12.5 and E16.5, GlyT2
expression was virtually eliminated in the dorsal horn (Figs. 1E–H).
In the dorsal horn of Pax2−/− mice, GlyT2 expression was also
eliminated at E12.5 and markedly diminished at E18.5 (Figs. 1I–L).
Marked reduction of GlyT2 expression was also observed in the
dorsal spinal cord of E12.5 Lbx1−/− embryos (Figs. 1M and N). In
contrast, glycinergic neuron differentiation in the ventral spinal cord
was largely unaffected in these mutants (Figs. 1E–N), consistent with
a lack of Pax2 expression in many GABAergic and glycinergic
neurons in the ventral horn (Pillai et al., 2007). Ptf1a, Pax2 and Lbx1
are therefore selectively required for the development of dorsal
spinal glycinergic neurons.
Several observations suggested that the loss of GlyT2 in the Ptf1a−/−
dorsal spinal cord was not due to a loss of neurons. First, the TUNEL
assay failed to showan increase in cell death in Ptf1a−/−mice at various
Fig. 1. Ptf1a, Lbx1 and Pax2 are required for glycinergic differentiation. (A–D) GlyT2 expressionwas detected by in situ hybridization on transverse sections of wild-type dorsal horn at
E12.5 (A) and P0 (C). Pseudo-color double staining of nuclear Pax2 protein (B, D, green) and cytoplasmic GlyT2mRNA (B, D, red) are shown in the boxed area of panels A and C. Panels
B and D are confocal images, inwhich bright-ﬁeld in situ hybridization signals were converted into red pseudo-ﬂuorescent signals. Many cells expressed both GlyT2 and Pax2 at E12.5
and P0 wild-type dorsal horn (B, D, arrows), however, some neurons expressed only GlyT2 or Pax2 (B, D, arrowheads). The dashed line in panel C represents the surface of the spinal
cord. (E–N) In situ hybridization was performed with GlyT2 on transverse sections of wild-type and Ptf1a−/− spinal cord at E12.5 and E16.5, wild-type and Pax2−/− spinal cord at E12.5
and E18.5 and wild-type and Lbx1−/− spinal cord at E12.5. Note the loss of GlyT2 expression in the dorsal (arrows) but not the ventral (arrowheads) spinal cord. The dashed lines in
panels F–H, J–L and N represent the surface of the spinal cord. Scale bars: 50 µm in panels A, C, E–N; 20 µm in panels B, D.
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there was no reduction in neuronal cells in Ptf1amutants, as indicated
by the expression of the pan-neuronal marker Stmn2 (also known as
SCG10) (Stein et al., 1988) and the dorsal horn neuron marker Hoxb8
(Graham et al., 1991) (Supplementary Figs. 1A–F). Third, a previous
study reported that prospective Pax2-expressing inhibitory neuronswere transformed into glutamatergic neurons in Ptf1a−/− mice
(Glasgow et al., 2005). Similarly, loss of GlyT2 expression in Lbx1
mutants was detected at E12.5, prior to reported increased cell death
at E13.5 (Gross et al., 2002). Taken together, these observations show
that Ptf1a and Lbx1 are required to specify the glycinergic transmitter
phenotype, at least during the embryonic stages.
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GABAergic cell differentiation
Lbx1 is sufﬁcient to cause a switch from a glutamatergic to a
GABAergic cell fate (Cheng et al., 2005). To determine if Lbx1, Pax2, and
Ptf1a are also sufﬁcient to promote glycinergic differentiation, we
electroporated chick brachial neural tubes at stage 13–14 with a
construct expressing mouse Lbx1, Pax2, or Ptf1a and analyzed the
phenotype two days later. In the embryonic chick neural tube, two of
six dorsal interneuron populations, DI4 and DI6, express Pax2 (Gross
et al., 2002). Pax2 was expressed in glycinergic neurons in mouse
dorsal spinal cord (Figs. 1A–D). Accordingly, expression of GlyT2 in the
chick dorsal neural tube appeared in two distinct populations, which
likely corresponded to DI4 and DI6, respectively. After ectopic
expression of Lbx1, Pax2, or Ptf1a on the electroporated side, the
disappearance of the gap between the presumptive DI4 and DI6
neurons provided the most convincing and qualitative indication of
ectopic expression of GlyT2 (Figs. 2A–G). Ectopic GlyT2 expression did
occur in areas above the presumptive DI4 neurons (Fig. 2B and
Supplementary Fig. 2A–E).
Interestingly, overexpression of Pax2 or Ptf1a also resulted in
ectopic expression of the GABAergic neuronal marker Gad1 on the
electroporated side (Figs. 2C–H and Supplementary Figs. 2A–F). We
previously reported that ectopic expression of Pax2 in chick neural
tubes did not induce ectopic GABAergic differentiation (Cheng et al.,
2004). The reason why we didn't observe ectopic Gad1 expression
after Pax2 overexpression in our previous study may be ascribed to
the low efﬁcacy of Pax2 expression. In our previous study, Pax2 was
expressed from a β-actin promoter driven vector, and only a low
percentage of cells expressed Pax2, which makes it difﬁcult for
induced Gad1 to ﬁll the gap between the presumptive D14 and DI6
domains. In current study, Pax2 expression was driven by RCASBP
vector, which is replication-competent and can achieve a relatively
high ectopic Pax2 expression on the electroporated side, thereby
allowing us to detect an ectopic Gad1 induction. The homeobox gene
Lhx1 recently has been reported to maintain inhibitory neurotrans-
mitter status (Pillai et al., 2007). Overexpression of Lhx1 in chick
neural tubes was, however, unable to promote ectopic GABAergic or
glycinergic differentiation (data not shown). As a negative control,
overexpression of the empty vector RCASBP had no effect on the
expression of GlyT2 or Gad1 (Figs. 2I–K).
These ﬁndings suggest that overexpression of Lbx1, Pax2 or Ptf1a is
sufﬁcient to promote ectopic glycinergic and GABAergic neuron
differentiation in the chick dorsal spinal cord.
Dynamic expression of peptide genes in the dorsal horn
In addition to GABA and glycine, many transmitters including
neuropeptides ENK, NPY and GAL, are expressed in subpopulations of
GABAergic neurons in the dorsal horn of spinal cord (Rowan et al.,
1993; Simmons et al., 1995; Todd et al., 1992). Other peptides also are
expressed in sub-populations of the dorsal spinal cord, such as
nociceptin/orphanin FQ (N/OFQ) and dynorphin (DYN) (Cruz and
Basbaum, 1985; Riedl et al., 1996; Schulz et al., 1996). In this study, we
examined the expression of the following peptide genes: Neuropep-
tide Y (Npy) which encodes NPY; Prepronociceptin (Pnoc) which
encodes the precursor for N/OFQ; Preproenkephalin (Penk1) which
encodes the precursor for ENK; Prodynorphin (Pdyn) which encodes
the precursor for DYN; and Galanin (Gal) which encodes GAL.
Based on in situ hybridization data, most of the peptide genes
exhibited dynamic expression patterns in the developing dorsal horn
(E12.5-P0) (Fig. 3) leading us to draw several conclusions. First, the
transmitter phenotypes emerge at distinct dates in the dorsal horn.
The expression of Npy and Pnoc is initiated around E12.5 (Figs. 3A and
E), while the expression of Penk1, Pdyn and Gal is initiated around
E16.5 (Figs. 3I–J, M–N, Q–R). Second, Npy and Pnoc were expressed inthe ventral spinal cord at E12.5, but their ventral expression was
progressively extinguished during late development. Npy and Pnoc
lost most of their ventral expression at E14.5 and after P0, respectively
(Figs. 3A–H). Penk1 expression in the ventral spinal cord was also lost
at P30 (Fig. 3L). Third, at the postnatal stage P30, all of the peptide
genes exhibited distinct expression patterns, with Pnoc, Pdyn, and Gal
expression enriched in the superﬁcial laminae (Figs. 3H, P and T) and
Npy and Penk1 expression scattered throughout the dorsal horn
(Figs. 3D and L).
As mentioned above, Pax2 is a marker for GABAergic neurons
during the early embryonic stages (Cheng et al., 2004). To determine if
any of these peptide-expressing cells were associated with Pax2+ cells,
we went on to combine Pax2 immunostaining with in situ hybridiza-
tion using peptide genes as the probes.
At E12.5, most Npy-expressing cells that were located adjacent to
the ventricular zone also expressed Pax2, which likely represents
newly formed neurons (Figs. 4A and B). However, at the more lateral
region, subpopulations of Npy-expressing cells did not express Pax2
(Figs. 4A and B). This partial-overlapping expression of Npy and Pax2
was also observed at P0 (Figs. 4C and D). We will show below that Npy
expression in the dorsal horn was eliminated in Pax2 mutants. Taken
together, we conclude that Npy-expressing neurons in the dorsal horn
exhibited persistent or transient Pax2 expression.
Most Pnoc-expressing neurons showed a partial-overlapping with
Pax2 at both E12.5 and P0 (Figs. 4E–H). Many Penk1-, Pdyn- and Gal-
expressing neurons also overlapped partially with Pax2 (Figs. 4I–N). It
has also been shown that two waves of Somatostatin (Sst) expression,
which encode the peptide somatostatin (SOM), were observed in
developing dorsal spinal cord,with early expression largely conﬁned in
Pax2+ neurons thatwere located in deep dorsal horn laminae (Xu et al.,
2008). Taken together, we conclude that Pax2-expressing inhibitory
neurons expressed a set of peptide genes, including Npy, Pnoc, Penk1,
Pdyn, Gal, and Sst. This association is further supported by a require-
ment of Pax2 for the expression of Npy, Pnoc, Pdyn, Gal (see below).
Ptf1a is required for peptide gene expression in the dorsal horn
We next examined if Ptf1a was necessary for peptide gene
expression in these neurons. In situ hybridization data showed that
Npy and Pnoc expression was eliminated in the dorsal horn of Ptf1a−/−
embryos at both the early stage E12.5 and late stage E16.5 (Figs. 5A–H).
Sst expression was abolished in the dorsal horn of Ptf1a−/− embryos at
E12.5 (Figs. 5I and J). At P0, Sst expressionwas selectively eliminated in
the deep laminae of the dorsal horn of Ptf1a−/− embryos (Figs. 5K, L),
with total number of Sst+ cells per quadrant reduced from 185±19 in
wild-typemice to 142±8 in Ptf1a−/−mice (Pb0.05). The selective loss of
Sst expression in deep laminae is consistent with the observation that
the early wave of Sst expression is largely conﬁned in Pax2+ neurons
that settle in the deep laminae, whereas the latewave of Sst expression
is conﬁned toTlx3+ excitatory neurons that settle in superﬁcial laminae
(Xu et al., 2008).
Late onset of peptide gene expression was also examined.
Expression of Penk1, Pdyn, and Gal were reduced dramatically in the
thoracic dorsal horn from Ptf1a−/−mutant embryos at E16.5 or P0 (Figs.
5M–R). The number of Penk1+ cells per quadrant was reduced from
67±4 inwild-typemice to 10±1 in Ptf1a−/−mice (Pb0.01); the number
of Pdyn+ cells was reduced from 54±3 to 3±2 (Pb0.01); and, the
number of Gal+ cells per quadrant was reduced from 44±9 to 4±1 in
Ptf1a−/− embryos (Pb0.01). These results indicate that Ptf1a is required
for expression of a set of peptide genes that are normally expressed in
Pax2+ inhibitory neurons.
Pax2 is required for the expression of Npy, Pnoc, Pdyn and Gal
Pax2 is a downstream target of Ptf1a (Glasgow et al., 2005). We
then asked if Pax2 was necessary for Ptf1a-dependent peptide gene
Fig. 2. Overexpression of Lbx1, Pax2 or Ptf1a in the chick neural tube promotes ectopic glycinergic and GABAergic differentiation. (A–H) Transverse sections of an E4.5 chick spinal
cord, with the right side of the neural tube electroporated with a mouse Lbx1, Pax2 or Ptf1a expression construct (RCAS-Lbx1, RCAS-Pax2 or RCAS-Ptf1a). In situ hybridization was
performed with Lbx1, GlyT2, Pax2, Gad1 or Ptf1a as the probe. Lbx1, Pax2 or Ptf1awas expressed throughout the entire spinal cord on the electroporated side (A, C and F, arrows). On
the non-electroporated side, there was a gap between the twomost dorsal patches of GlyT2+ (B, D and G) and Gad1+ neurons (E and H), which are likely to correspond to DI4 and DI6
neurons, respectively. On the electroporated side, the gap between DI4 and DI6 was ﬁlled by ectopic expression of GlyT2 or Gad1 (B, ventral arrowhead; D, E, G and H, arrowheads). In
addition, overexpression of Lbx1 promoted GlyT2 expression in areas above DI4 (B, dorsal arrowhead). (I–K) Electroporation of the chick neural tubewith control vectors (RCASBP plus
pCAX-GFP) was performed. GFP expression was used to monitor electroporation efﬁcacy (I, arrow). Note the lack of GlyT2 and Gad1 induction after overexpression with control
vectors (J and K, arrowheads). Scale bars: 50 µm in panels A–K.
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Fig. 3. Expression of peptide genes in the developing spinal cord of mouse. (A–T) In situ hybridization was performed on sections of the spinal cord at various developmental
stages using peptide genes as the probes. (A–D) At E12.5, Npy was expressed in the dorsal (A, arrow) and ventral (A, arrowhead) spinal cord. By E14.5, Npy expression was
scattered over the superﬁcial laminae of the dorsal spinal cord whereas most of its expression in the ventral spinal cord was lost (B). At P0 and P30, Npy continued to
scatter over the superﬁcial laminae (C and D). (E–H) Pnoc expression was observed in the dorsal and ventral spinal cord at E12.5, E14.5 and P0 (E–G). At P30, the Pnoc
expression was enriched in the superﬁcial laminae with the remaining was expressed around the dorsal ventricular area (H). (I–L) At E14.5, Penk1 was expressed in the
ventral but not the dorsal spinal cord (I). At E16.5 and P0, Penk1 expression was scattered throughout the spinal cord (J and K). At P30, Penk1 expression was markedly
reduced in the ventral spinal cord (L). (M–P) At E14.5, Pdyn was expressed in the dorsal and ventral ventricular area (M). From E16.5 and on, Pdyn expression was enriched
in superﬁcial laminae of the dorsal spinal cord (N–P). (Q–T) Until E14.5, Gal was not expressed in the spinal cord (Q). At E16.5, Gal was expressed weakly in the dorsal
spinal cord (R) and at P0, its expression was scattered over the dorsal horn (S). At P30, Gal was enriched in the superﬁcial laminae of the dorsal horn (T). Scale bars:
100 µm in panels A–T.
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expression was essentially eliminated in Pax2−/− dorsal horns at
E12.5 (Figs. 6A–B and E–F). A marked reduction of Npy and Pnoc was
also observed at E18.5 (Figs. 6C, D and G, H). The number of Npy+
cells per quadrant reduced from 154±28 in wild-type mice to 61±3
in Pax2−/− mice (Pb0.05) and the number of Pnoc+ cells reduced from
102±8 to 13±2 (Pb0.01). The incomplete loss of Npy and Pnoc in
Pax2−/− mice suggests that Ptf1a-dependent Npy and Pnoc expression
could be sub-divided into Pax2-dependent and Pax2-independent
sub-populations.
Sst was largely unaffected in Pax2−/− embryos. In E12.5 embryos
(Figs. 6I and J), the number of Sst+ cells per quadrant was 51±15 in
wild-type mice versus 45±11 in Pax2−/− mice (PN0.5). In E18.5embryos (Figs. 6K and L), the number of Sst+ cells per quadrant was
184±6 inwild-type mice versus 180±10 in E18.5 Pax2−/−mice (PN0.5),
implying that Sst expression was largely Pax2-independent.
We also examined late onset peptide gene expression in the
thoracic dorsal horn of E18.5 Pax2−/− embryos. Pdyn expression was
largely eliminated (Figs. 6M and N), with the number of Pdyn+ cells per
quadrant reduced from 57±4 inwild-type mice to 7±1 in Pax2−/−mice
(Pb0.01). Gal expression was also signiﬁcantly diminished (Figs. 6O–
P), with the number of Gal+ cells per quadrant reduced from 52±8 in
wild-type mice to 18±3 in Pax2−/− embryos (Pb0.01). Expression of
Penk1, however, remained unaffected: the number of Penk1+ cells per
quadrant was 93±19 in wild-type mice and 89±6 in Pax2−/− mice
(PN0.5). However, the distribution of Penk1-expressing neurons
400 M. Huang et al. / Developmental Biology 322 (2008) 394–405appeared to be changed, suggesting a possible defect in neuronal
migration (Figs. 6Q and R).
These results indicate that Pax2 is required completely or partially
for the expression ofNpy, Pnoc, Pdyn and Gal, but is largely dispensable
for Sst and Penk1 expression in the dorsal horn. In other words, Pax2 is
only partially responsible for Ptf1a-dependent differentiation
programs.Fig. 4. Expression of Npy, Pnoc, Penk1, Pdyn and Gal in Pax2+ neurons. (A–N) Pseudo-color
(A–D, red), Pnoc (E–H, red), Penk1 (I–J, red), Pdyn (K–L, red) or Gal (M–N, red) mRNA on sp
in which bright-ﬁeld in situ hybridization signals were converted into red pseudo-ﬂuoresc
horn (B, arrows). However, there are cells that expressed only Npy or Pax2 (B, arrowhea
arrowheads). (E–N) Partial co-localization of Pnoc (E-H), Penk1 (I–J), Pdyn (K–L) and Gal (M
G, I, K, M; 20 µm in panels B, D, F, H, J, L, N.Lbx1 is required for the early wave of peptide gene expression
We next examined peptide gene expression in Lbx1−/− embryos.
The analyses focused on Npy, Pnoc and Sst peptide genes whose
expression is established at early embryonic stages, because massive
cell loss occurs after E13.5 in Lbx1 mutants (Gross et al., 2002). In situ
hybridization data showed that Npy and Pnoc expressionwas virtuallydouble staining of nuclear Pax2 protein (B, D, F, H, J, L, N, green) and cytoplasmic Npy
inal cord sections at indicated stages. Panels B, D, F, H, J, L and N are confocal images,
ent signals. (A–D) Many cells expressed Npy and Pax2 at E12.5 in the wild-type dorsal
ds). Partial co-localization of Npy and Pax2 was also observed at P0 (D, arrows and
–N) with Pax2 (F, H, J, L, N, arrows) was observed. Scale bars: 50 µm in Panels A, C, E,
Fig. 5. Loss of peptide gene expression in Ptf1a−/− mice. (A–R) In situ hybridization was performed on sections of wild-type or Ptf1a−/− thoracic spinal cords at E12.5, E16.5 or P0. The
dashed lines represent the surface of the spinal cord. (A–H) Note the loss of peptide gene expression ofNpy and Pnoc in the dorsal (arrows) but not the ventral spinal cord (arrowheads)
of Ptf1a mutants. (I–L) Sst expression was eliminated in the dorsal horn of Ptf1a−/− mice at E12.5 and selectively abolished in the deep laminae of the Ptf1a−/− dorsal horn at P0
(I–L, arrows) butwas largely unchanged in the ventral horn (I–L, arrowheads). (M–N) Penk1 expressionwas reduced dramatically in the dorsal horn (arrow) but persisted in the ventral
horn of E16.5 Ptf1a−/− mice (arrowheads). (O–R) Pdyn and Gal expression were markedly reduced in the dorsal horn of Ptf1a mutants (arrows). Scale bars: 50 µm in panels A–R.
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Fig. 6. Peptide gene expression in Pax2−/− mice. (A–R) In situ hybridization was performed on sections of thoracic spinal cord fromwild-type or Pax2−/− at E12.5 or E18.5. The dashed
lines represent the surface of the spinal cord. (A–H) Note the loss or reduction of Npy and Pnoc expression in the dorsal (arrows) but not the ventral spinal cord of Pax2−/− mice
(arrowheads). (I–L) Though Sst expression largely remained unaffected in the ventral spinal cord (arrowheads) and dorsal horn of E18.5 Pax2−/− embryos (K, L, arrow), subpopulations
of Sst+ neurons were scattered over the intermediate area of the dorsal horn in E12.5 Pax2−/−mice compared with wild-type (I, J, arrows). (M–P) Note the loss or reduction of Pdyn and
Gal expression in the dorsal (arrows) but not the ventral spinal cord (arrowheads) of E18.5 Pax2−/− mice. (Q, R) Penk1 accumulated abnormally in the lateral region (arrows) of the
E18.5 Pax2−/− dorsal horn and remained largely unchanged in the deep laminae of the dorsal horn and the ventral horn (arrowheads), indicative of a migration defect of Penk1-
expressing neurons in the E18.5 Pax2−/− dorsal horn. Scale bars: 50 µm in panels A–R.
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Fig. 7. Expression of peptide genes Npy, Pnoc and an early wave of Sst in Lbx1−/− mice.
(A–F) In situ hybridization was performed on sections of thoracic spinal cords from
wild-type or Lbx1−/− at E12.5. The dashed lines represent the surface of the spinal cord.
(A–D) Note the loss of Npy and Pnoc expression in the dorsal (arrows) but not the
ventral spinal cord (arrowheads). (E, F) Sst expression was diminished in the superﬁcial
laminae (arrows) and scattered over the intermediate area of dorsal spinal cord (F, short
arrow) in Lbx1−/− embryos, whereas its expression remained largely unchanged in the
ventral spinal cord (arrowheads). Scale bars: 50 µm in panels A–F.
Fig. 8. A model for the roles of transcription factors Ptf1a, Lbx1 and Pax2 in specifying
the inhibitory neurons in the dorsal spinal cord. Ptf1a acts in combination with Lbx1 to
control Pax2-dependent differentiation programs which include GABAergic, glycinergic,
Npy+, Pnoc+, Pdyn+ and Gal+ peptidergic cell fate. On the other hand, Ptf1a speciﬁes the
early wave of Sst+ neurons and subpopulations of Penk1+ neurons in a Pax2-independent
fashion.
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however, only slightly diminished (Figs. 7E and F), with the number
of Sst+ cells per quadrant reduced from 48±5 in E12.5 wild-type
mice to 32±4 in Lbx1−/− mice (Pb0.05). These results suggest that
Lbx1 is required completely or partially for the expression of Npy,
Pnoc and Sst.
Derepression of peptide gene expression in mice that lack Tlx1 and
Tlx3
Spinal GABAergic markers, including Pax2, Gad1/2 and Viaat, are
derepressed in Tlx1−/−;Tlx3−/− (Tlx1/3−/−) compound mutants (Cheng et
al., 2004). Here we wanted to assess to what degree inhibitory neuron
markers were derepressed in Tlx1/3−/− mutants. In situ hybridization
data showed that the numbers of neurons expressing GlyT2, Npy, or
Pnoc were markedly increased in Tlx1/3−/− mutant embryos (Supple-
mentary Fig. 3). However, the expression of late onset peptide genes
including Penk1 and Gal was comparable in Tlx1/3−/− mice versus the
wild-type control (Xu et al., 2008 and data not shown). This data
suggests that Tlx1 and Tlx3 are only required for the suppression of a
portion of inhibitory neuron markers.Discussion
Transmitter phenotypes in dorsal horn inhibitory neurons
Our current study shows that dorsal horn inhibitory neurons,
marked by the persistent Pax2 expression or revealed by the
dependence of their expression on Pax2 and/or Ptf1a, express a set
of genes encoding neurotransmitter phenotypes, including glycine
and a set of neuropeptides (NPY, N/OFQ, SOM, ENK, DYN and GAL).
The association of the glycinergic neuron marker GlyT2 in a subset of
Pax2+ neurons is consistent with previous ﬁndings that some dorsal
horn GABAergic neurons co-release glycine (Todd, 1996; Todd and
Sullivan, 1990). The association between neuropeptides (NPY, GAL,
and ENK) and Pax2+ neurons is also consistent with the reported
expression of these peptides in dorsal horn inhibitory neurons
(Rowan et al., 1993; Simmons et al., 1995; Todd et al., 1992). While
our study shows that ENK is expressed in many Pax2+ neurons, and
therefore presumably inhibitory neurons, two recent studies demon-
strated that some VLUT2-IR axonal boutons in rat and hamster spinal
dorsal horn also contain enkephalin, suggesting that enkephalin is
also expressed in glutamatergic neurons (Schneider and Walker,
2007; Todd et al., 2003). It should be pointed out that in these two
studies, punctuate VGLUT2 and ENK staining was associated with
axonal varicosities and not with neuronal somata (Schneider and
Walker, 2007; Todd et al., 2003), therefore the cellular source of
these ENK+ glutamatergic synaptic boutons is unclear. In contrast, we
used in situ hybridization to reveal the cell bodies for Penk1-
expressing Pax2+ neurons. We therefore propose that local spinal
ENK+ Pax2+ neurons might represent inhibitory neurons, whereas
ENK+ VGLUT2+ ﬁbers shown in previous studies might be derived
from other sources, such as the descending ﬁbers from the
hindbrain. Our studies, however, do not rule out the formal
possibility that some Pax2+ neurons, which are GABAergic neurons
at embryonic stages (E16.5 and P0), switch to glutamatergic neurons
in the mature spinal cord.
A hierarchical regulation of neurotransmitter phenotypes in dorsal horn
inhibitory neurons
We and others have shown before that Lbx1, Pax2, and Ptf1a are
required for GABAergic neurotransmitter speciﬁcation in the embryo-
nic dorsal spinal cord (Cheng et al., 2004, 2005; Glasgow et al., 2005;
Gross et al., 2002; Muller et al., 2002). In the current study, we
provide genetic evidence that these same transcription factors, Ptf1a,
Pax2 and Lbx1, coordinate the speciﬁcation of GABAergic, glycinergic
and peptidergic transmitter phenotypes in the dorsal spinal cord
(Figs. 1, 5–8).
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complete loss or marked reduction of markers that deﬁne GABAergic,
glycinergic and peptidergic transmitter phenotypes, including Gad1,
Viaat, GlyT2, and a set of peptide genes including Npy, Pnoc, an early
wave of Sst, Penk1, Pdyn and Gal. Pax2, a downstream target of Ptf1a,
is required to control a large portion of Ptf1a-dependent transmitter
phenotypes, with Sst and Penk1 as the exceptions. Lbx1 may act
primarily through Pax2 in controlling dorsal horn inhibitory neuron
differentiation, as suggested by the observation that expression of all
Pax2-dependent genes (Gad1, GlyT2, Npy and Pnoc), but not Pax2-
independent genes (such as Sst), are eliminated in Lbx1mutants (Figs.
1, 6–8). As Lbx1 deﬁciency leads to a progressive loss of dorsal horn
neurons starting at E13.5, it is still unclear what roles Lbx1may play in
controlling late onset peptide gene expression, such as Pdyn and Gal
(Gross et al., 2002; Muller et al., 2002). In summary, Ptf1a operates at
high hierarch and acts through both Pax2-dependent and Pax2-
independent pathways to control inhibitory neuron differentiation
(Fig. 8).
The current study also reveals that the regulation of individual
peptide transmitters is complex. Npy and Pnoc expression can all be
further sub-divided into early Pax2-dependent and late Pax2-
independent sub-portions. In the case of Sst, an early wave of Sst
expression is dependent on Ptf1a, whereas the late wave of Sst
expression is conﬁned to Ptf1a-negative Tlx3-expressing excitatory
neurons (Xu et al., 2008). Such complexities in transcriptional
regulation may form a genetic basis for the generation of tremendous
diversity in dorsal horn neurons.
Incomplete cell fate transformation in Tlx1 and Tlx3 deﬁcient mice
We have reported previously that the homeobox genes Tlx1 and
Tlx3 determine excitatory neuron cell fate and their mutations result
in an impairment of glutamatergic differentiation and a concurrent
expansion of GABAergic neuronal markers, such as Pax2, Gad1 and
Viaat (Cheng et al., 2004). Subsequent studies show that Tlx1/3 acts
primarily through antagonizing Lbx1 to promote glutamatergic
differentiation and to suppress GABAergic differentiation (Cheng et
al., 2005). In support of this Tlx1/3 function, many Lbx1 and Pax2-
dependent genes, such as the expression of Gad1, GlyT2, Npy and
Pnoc, are derepressed in Tlx1/3 mutants. In other words, in the
absence of Tlx1 and Tlx3, most dorsal horn neurons are competent to
activate an Lbx1 and Pax2-dependent inhibitory neuron differentia-
tion program. It is also quite interesting to note that some of the Pax2-
independent genes, such as those peptides established at late stages
(Penk1 and Gal), do not exhibit an obvious expansion in Tlx1/3
mutants (Xu et al., 2008 and data not shown). In other words, Tlx1 and
Tlx3 are only required to suppress subsets of inhibitory neuron
markers and their mutations lead to an incomplete cell fate
transformation.
Regulation of inhibitory neuron phenotypes by region-speciﬁc
transcription factors
Ptf1a, Lbx1 and Pax2 are expressed in restricted regions in the
developing nervous system. Accordingly, development of inhibitory
neurons in other regions of the brain is controlled by a separate group
of transcription factors, including Dlx class homeobox genes and the
bHLH transcription factorMash1 in the forebrain, and the Heslike gene
in the midbrain (Fode et al., 2000; Miyoshi et al., 2004; Panganiban
and Rubenstein, 2002). Interestingly, Dlx genes may also play a role in
controlling peptidergic neuron development or survival in the
cerebral cortex (Cobos et al., 2005). These ﬁndings provide a new
line of evidence that speciﬁcation of broadly-distributed inhibitory
and peptide transmitters is controlled by region-speciﬁc transcription
factors. Identifying core transcription factors that coordinate a large
set of transmitter phenotypes may help to generate speciﬁc types ofinhibitory neurons in vitro for future functional and therapeutic
studies (as was shown for Ptf1a/Pax2/Lbx1 in the dorsal spinal cord).
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